CareTrust REIT, Inc. (CTRE)

CareTrust REIT offers a rare blend of meaningful yield and high growth, driven by accretive acquisitions and strong operator fundamentals. Recent UK expansion and a robust acquisition pipeline position CTRE for continued FFO/share growth, supported by demographic tailwinds and a rock-solid balance sheet. At 18.6x forward FFO, much of CTRE's growth appears priced into the stock.

Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.

The Dow Jones Equity All REIT index grew 0.59% during the recent week, while the MSCI US REIT index increased 0.71%. The healthcare REIT index was the sole Dow Jones US real estate sector property index to close the recent week in the red, down 1.57%. Cannabis-oriented Innovative Industrial Properties Inc. was the top-performing REIT stock above a $200 million market capitalization for the recent week, with a share-price gain of 14.01%.

CareTrust REIT (CTRE) continues to outperform peers and the market, driven by strong double-digit growth and strategic acquisitions, even in a tough macro environment. The company's low-leverage balance sheet and ample liquidity provide flexibility for continued investment and position CTRE for further growth as interest rates decline. Management has raised full-year FFO and FAD guidance, reinforcing dividend safety and highlighting robust operational performance despite minor earnings misses.

U.S. equity markets climbed to fresh record highs this week despite a jump in producer prices, but consumer inflation remained "cool enough" to keep the Fed on-course for September rate cuts. Despite the inflation uptick in July, all three major CPI and PPI metrics remained below the annualized levels seen in January preceding the initial wave of tariffs. Ahead of the Chair Powell's "farewell tour" in Jackson Hole, the inevitability of significantly easier monetary policy by mid-2026 - at the latest- has fully taken hold in recent weeks.

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--CareTrust REIT, Inc. (NYSE: CTRE) (“CareTrust REIT” or the “Company”) announced the pricing of its upsized underwritten public offering of 20,000,000 shares of common stock at a price to the public of $32.00 per share. The offering is expected to close on August 14, 2025, subject to customary closing conditions. In connection with the offering, the Company has granted the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of comm.

CareTrust REIT, Inc. (NYSE:CTRE ) Q2 2025 Earnings Conference Call August 7, 2025 1:00 PM ET Company Participants David M. Sedgwick - CEO, President & Director Derek J.

Although the revenue and EPS for CareTrust REIT (CTRE) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

CareTrust REIT (CTRE) came out with quarterly funds from operations (FFO) of $0.43 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to FFO of $0.36 per share a year ago.

CareTrust REIT (CTRE) Q2 Revenue Up 63%

CareTrust REIT (CTRE) is well positioned to outperform the market, as it exhibits above-average growth in financials.

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--CareTrust REIT Sets Second Quarter Earnings Call for Thursday, August 7, 2025.

CareTrust REIT (CTRE) is well positioned to outperform the market, as it exhibits above-average growth in financials.

REITs had another month of recovery in June (+2.56% average total return), but despite back-to-back gains remain in negative territory YTD (-5.65%). Micro cap REITs (+7.19%) outperformed for the first time this year in June, while small caps (+2.99%), mid caps (+1.80%) and large caps (+0.03%) saw smaller gains. 63.87% of REIT securities had a positive total return in June.

CTRE's recent UK expansion positions it for strong long-term growth, tapping into unmet demand for senior care and diversifying its portfolio. Despite higher headline valuation ratios, CTRE's PEG of 0.85x and sector-leading FFO growth make shares undervalued relative to future prospects, in my opinion. The REIT boasts robust financials: low leverage, high cash reserves, strong dividend yield, and impressive 1Q2025 revenue and earnings growth.

CareTrust REIT offers strong total return potential, combining a solid yield with robust growth, justifying its premium valuation for long-term investors. It has a high-quality operator base, prudent capital management, and transformative U.K. acquisition that's accretive in year one. A fortress balance sheet, well-covered and growing dividend, and a healthy acquisition pipeline position CTRE for sustainable FFO and dividend growth.